iSpecimen Inc.
ISPC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.05 | 0.01 | 0.00 | -0.00 |
| FCF Yield | -27.02% | -7.87% | -145.43% | -183.28% |
| EV / EBITDA | -2.13 | -3.49 | -0.22 | -0.06 |
| Quality | ||||
| ROIC | -84.38% | -200.19% | -83.22% | -161.20% |
| Gross Margin | -91.94% | 37.71% | 37.85% | 10.26% |
| Cash Conversion Ratio | 0.73 | 0.18 | 0.66 | 0.57 |
| Growth | ||||
| Revenue 3-Year CAGR | -31.24% | -16.42% | -9.39% | -3.70% |
| Free Cash Flow Growth | -956.43% | 82.42% | 68.38% | -175.18% |
| Safety | ||||
| Net Debt / EBITDA | 1.06 | 0.49 | 0.40 | 0.30 |
| Interest Coverage | 0.00 | 0.00 | -79.98 | -28.66 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -1,996.66 | -827.31 | -468.93 | -197.18 |